Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • SkinJet

    - PMLiVE

    Medicus Pharma completes patient enrolment for basal cell carcinoma trial

    Interim results have shown over 60% clinical clearance in patients treated with SkinJect

    - PMLiVE

    Medicus Pharma recruits first patient in cancer patch trial

    The first patient has been dosed as part of a phase 2 trial in the UAE

    - PMLiVE

    EU green light for Novartis’ skin cancer therapy

    Swiss firm’s basal cell carcinoma treatment can now be launched across Europe

    - PMLiVE

    Ten new medicines recommended in Europe

    Includes double approvals for rare disease specialist Alexion and Novartis

    Novartis building

    Novartis skin cancer drug clears pivotal trial

    Sonidegib achieves significant response in basal cell carcinoma patients

    Roche - Basel

    Roche’s Erivedge authorised in UK

    Available for skin cancer patients through Cancer Drugs Fund

    Roche - Basel

    Roche wins conditional EU approval for cancer drug Erivedge

    Can market it for advanced basal cell carcinoma but must provide more safety data

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links